SF3B1 and myelodysplastic syndrome: In our multivariate analysis, IPSS stratification, DNMT3A and SF3B1 mutations could significantly predict the outcome of younger patients (<60 years), in addition to these, hypomethylation of MIR‐378 also acts as a risk factor independently, providing helpful information for the prognosis of MDS.